0001991732-25-000002.txt : 20250715 0001991732-25-000002.hdr.sgml : 20250715 20250715102339 ACCESSION NUMBER: 0001991732-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250715 DATE AS OF CHANGE: 20250715 EFFECTIVENESS DATE: 20250715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cantai Therapeutics, Inc. CENTRAL INDEX KEY: 0001991732 ORGANIZATION NAME: EIN: 933026358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-551755 FILM NUMBER: 251123494 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPIA STATE: PA ZIP: 19104 BUSINESS PHONE: 603-996-1218 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPIA STATE: PA ZIP: 19104 D 1 primary_doc.xml X0708 D LIVE 0001991732 Cantai Therapeutics, Inc. 3675 MARKET STREET SUITE 200 PHILADELPIA PA PENNSYLVANIA 19104 603-996-1218 DELAWARE None None Corporation true 2023 Ross Leimberg 3675 Market Street , Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Errik Anderson 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Geeta Vemuri 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Joshua Brandt 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Biotechnology Decline to Disclose 06b false 2025-07-02 false true false 0 1100000 550000 550000 false 3 0 0 0 true false Cantai Therapeutics, Inc. Ross Leimberg Ross Leimberg Chief Operating Officer and Interim CEO 2025-07-15